Thymosin Beta-4 (Tβ4)

Full Tβ4 vs. TB-500 — the actual difference

Every cell in the human body contains Thymosin Beta-4 in high concentrations — it is one of the most abundant intracellular peptides in mammalian cells. Its primary function is actin sequestration: binding G-actin (monomeric actin) to regulate the pool available for polymerization, governing cell shape, migration, and division. TB-500 was created as a practical injectable form of the active region of Tβ4 — the 17-amino-acid LKKTETQ fragment that retains the actin-binding and cell migration properties.

Full-length Tβ4 has additional biological activities beyond the TB-500 fragment. Most critically: cardiac progenitor cell activation, demonstrated in landmark Nature papers where Tβ4 reactivated dormant epicardial cells after myocardial infarction, causing them to differentiate into cardiomyocytes and vascular smooth muscle. This mechanism is specific to the full-length protein's interaction with integrin-linked kinase (ILK) — TB-500 does not fully replicate it.

Practical choice: for most tissue repair and injury recovery, TB-500 is the pragmatic option with more accumulated community data. Full Tβ4 is the choice when specifically targeting the cardiac repair mechanism, or wanting the complete biological profile of the natural protein.

How it works

Actin Sequestration — Shared with TB-500

Full Tβ4 contains the same LKKTETQ actin-binding sequence that TB-500 is derived from. It sequesters G-actin, regulating cytoskeleton dynamics that govern cell migration, shape, and division. Wound healing, tissue repair, and angiogenic mechanisms are shared between the full protein and the TB-500 fragment.

Cardiac Progenitor Cell Activation — Unique to Full Tβ4

The 2007 Smart et al. Naturepaper demonstrated that Tβ4 activates dormant cardiac progenitor cells (epicardial cells) after myocardial infarction — causing differentiation into cardiomyocytes and vascular smooth muscle cells. This cardiac regeneration mechanism is specific to the full-length protein's interaction with integrin-linked kinase (ILK), not captured by the TB-500 fragment. This is the biological basis for Tβ4's cardiac repair clinical development.

Ophthalmic Effects

Tβ4 promotes corneal epithelial cell migration, angiogenesis in the limbal vasculature, and anti-inflammatory effects on the ocular surface. Eye drops deliver Tβ4 directly to corneal tissue without systemic exposure — the most clinically advanced pathway, with Phase III data for dry eye and neurotrophic keratopathy (RGN-259).

Anti-Inflammatory and Immunomodulatory

Full Tβ4 has broader anti-inflammatory effects than TB-500 — NF-κB suppression, TNF-α reduction, and modulation of dendritic cell function. The full protein's immunomodulatory profile is more complete than the fragment.

What the research shows

Community knowledge

Full Tβ4 is less commonly used in biohacker communities than TB-500 — partly expense and availability, partly more accumulated protocol data for the fragment. Users who specifically seek full Tβ4 are typically those who have researched the cardiac progenitor cell activation literature and want the additional biological activities. General tissue repair reports are similar to TB-500. Post-cardiovascular event use is a specific community application — some users target full Tβ4 rather than TB-500 specifically for the cardiac mechanism.